Structured Combined Exercise Program in Postmenopausal Women: Effects on Heart Rate Variability a… (NCT07615790) | Clinical Trial Compass
RecruitingNot Applicable
Structured Combined Exercise Program in Postmenopausal Women: Effects on Heart Rate Variability and Menopausal Symptoms
Turkey (Türkiye)40 participantsStarted 2026-04-27
Plain-language summary
The goal of this clinical trial is to learn whether a structured combined exercise program can improve heart health, menopausal symptoms, sleep quality, and quality of life in postmenopausal women aged 45 to 65 years.
The main questions it aims to answer are:
Does the exercise program improve heart rate variability, which shows how well the heart is controlled by the nervous system? Does the exercise program lower menopausal symptoms? Does the exercise program improve sleep quality and quality of life?
Researchers will compare women who join the exercise program with women who continue their usual daily activities.
Participants in the exercise group will take part in a supervised exercise program for 12 weeks. They will exercise 2 days each week. Each session will last 45 minutes and will include warm-up, balance, strengthening, coordination, flexibility, and cool-down exercises.
Participants in the control group will continue their usual daily activities during the study.
Who can participate
Age range
45 Years – 65 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Women in the postmenopausal period
* Aged between 45 and 65 years
* Able to communicate and cooperate with the researchers
* Not participating in another structured exercise program
* Willing to participate voluntarily in the study
Exclusion Criteria:
* Presence of severe cardiovascular, neurological, orthopedic, or psychiatric disease
* Hormone replacement therapy use during the study period
* Cognitive impairment affecting participation
* Uncontrolled hypertension or other unstable medical conditions
* Regular participation in structured exercise training within the last 6 months
* Smoking or alcohol use that may affect heart rate variability measurements
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Heart Rate Variability
Timeframe: Baseline, immediately after the 12-week intervention, and 8 weeks after the intervention